- This event has passed.
February 27, 2018 @ 11:00 am - 12:00 pm
Treatment of chronic pain requires “multimodal analgesia,” a management plan that often requires pharmacological as well as non-drug therapies, and very importantly large measures of clinician-guided patient self-management. Chronic pain management should rarely, if ever, be opioid mono-therapy. Understanding the clinical role and value of non-opioids, the so called “adjuvant” drugs, improves outcomes and reduces over-reliance on opioids and their demonstrated risks. Chronic pain is not a state of opioid deficiency.
In this webinar, you will learn to:
- Describe why chronic pain pharmacological treatment should not be opioid mono-therapy.
- Defend the role and value of non-drug options for management of chronic pain.
- Discuss the clinical value and potential side effects of commonly used “adjuvant” drugs in the management of chronic pain, including anti-inflammatories, antidepressants, and anticonvulsants.
- Understand why, when, and how alternatives to opioids improve outcomes of your pain management plan.
Click here to learn more and register.
Presenter: Dr. David J. Tauben, MD, FACP (Chief, University of Washington Division of Pain Medicine)